ReviewActa neurochirurgica2026
Management of chronic subdural hematoma: a consensus statement from the 2024 Copenhagen joint iCORIC/DACSUHS symposium.
Review in Acta neurochirurgica, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
26 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundChronic subdural hematoma (CSDH) is among the most common neurosurgical conditions, yet management strategies vary worldwide despite an expanding evidence base. To harmonize clinical practice and facilitate the establishment of transnational recommendations, the 2024 joint iCORIC/DACSUHS symposium in Copenhagen included a Delphi process on the key aspects of CSDH management.
methodsA modified Delphi process was conducted among 32 participants from 14 countries, including neurosurgeons, neurointerventionalists, and CSDH researchers. Eighteen topics were assessed across three survey rounds, based on the revised Danish national CSDH guidelines. Consensus was defined as ≥ 75% agreement and strong consensus as ≥ 95%.
resultsResponse rates were 84.3%, 100%, and 59.3% across the three rounds. Unanimous or strong consensus was achieved for several core practices: surgical evacuation for hematomas with significant mass effect, conservative management for mild cases, use of burr hole or twist-drill craniostomy as primary treatment, and postoperative drainage after evacuation. Consensus also supported irrigation with warm (37C°) Ringer's lactate, bilateral evacuation for large bilateral hematomas, and early postoperative mobilization. Areas lacking consensus included management of antithrombotic therapy, drain duration beyond 24 h, the role of routine postoperative Computed Tomography (CT) in asymptomatic patients, and the adoption of eMMA as standard or preventive treatment.
conclusionsThe 2024 iCORIC/DACSUHS Delphi consensus process identified broad international agreement on several aspects of CSDH management while exposing persisting disagreement in others including antithrombotic reversal, imaging protocols, and embolization strategies. Knowledge of the common understanding of agreement and disagreement within CSDH treatment form a platform for future multinational collaboration and highlight priorities for further clinical research.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.